E-Ring 8-Isoprostanes Are Agonists at EP2- and EP4-Prostanoid Receptors on Human Airway Smooth Muscle Cells and Regulate the Release of Colony-Stimulating Factors by Activating cAMP-Dependent Protein Kinase

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Molecular Pharmacology

• Publication date

  2005-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/MOL.104.006486PMID 15528403
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prostanoid receptor expression by human airway smooth muscle cells and regulation of the secretion of granulocyte colony-stimulating factor.

  2005cited by this paper
• Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM‐CSF

  2004cited by this paper
• E‐Ring 8‐isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea‐pig trachea through agonism of prostanoid receptors of the EP3‐subtype

  2004cited by this paper
• Adenovirus-Mediated Delivery and Expression of a cAMP-Dependent Protein Kinase Inhibitor Gene to BEAS-2B Epithelial Cells Abolishes the Anti-Inflammatory Effects of Rolipram, Salbutamol, and Prostaglandin E2: A Comparison with H-89

  2004cited by this paper
• Isoprostane-mediated secretion from human airway epithelial cells.

  2003cited by this paper
• Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer?

  2003cited by this paper
• Biomarkers of some pulmonary diseases in exhaled breath

  2002cited by this paper
• Tumor Necrosis Factor- α –Induced Secretion of RANTES and Interleukin-6 from Human Airway Smooth Muscle Cells: Modulation by Glucocorticoids and β -Agonists

  2002cited by this paper
• The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease.

  2002cited by this paper
• Key structural features of prostaglandin E(2) and prostanoid analogs involved in binding and activation of the human EP(1) prostanoid receptor.

  2001cited by this paper
• Effect of 8-iso-prostaglandin F(2 alpha) on acetylcholine release from parasympathetic nerves in guinea pig airways.

  2001cited by this paper
• Isoprostanes: an overview and putative roles in pulmonary pathophysiology.

  2001influential reference
• Prostanoid receptors: subtypes and signaling.

  2001influential reference
• Effect of 8-iso-prostaglandin F2α on acetylcholine release from parasympathetic nerves in guinea pig airways

  2001cited by this paper
• Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2).

  2001influential reference
• Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells. Modulation by cyclic adenosine monophosphate.

  2000cited by this paper
• Specificity and mechanism of action of some commonly used protein kinase inhibitors.

  2000cited by this paper
• Excitatory and inhibitory actions of isoprostanes in human and canine airway smooth muscle.

  2000cited by this paper
• Specificity and mechanism of action of some commonly used protein kinase inhibitors

  2000cited by this paper
• Indirect enhancement of neutrophil activity and adhesion to cultured human umbilical vein endothelial cells by isoprostanes (iPF2alpha-III and iPE2-III).

  1999cited by this paper
• Inhibitory prostanoid EP receptors in human non-pregnant myometrium.

  1999cited by this paper
• The isoprostanes: novel prostaglandin-like products of the free radical-catalyzed peroxidation of arachidonic acid.

  1999cited by this paper
• Coexpression studies with endothelin receptor subtypes indicate the existence of intracellular cross-talk between ET(A) and ET(B) receptors.

  1997cited by this paper
• A nomenclature system for the isoprostanes.

  1997cited by this paper
• Characterization of PKIγ, a Novel Isoform of the Protein Kinase Inhibitor of cAMP-dependent Protein Kinase*

  1997cited by this paper
• Necessity of dual blockade of endothelin ETA and ETB receptor subtypes for antagonism of endothelin‐1‐induced contraction in human bronchi

  1996cited by this paper
• Crystal Structures of Catalytic Subunit of cAMP-dependent Protein Kinase in Complex with Isoquinolinesulfonyl Protein Kinase Inhibitors H7, H8, and H89

  1996cited by this paper
• 8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro.

  1996cited by this paper
• 6-Isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist.

  1995cited by this paper
• Synergistic inhibition by BQ‐123 and BQ‐788 of endothelin‐1‐induced contractions of the rabbit pulmonary artery

  1994cited by this paper
• International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.

  1994cited by this paper
• VIII. International union of pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes

  1994cited by this paper
• Evidence for two additional isoforms of the endogenous protein kinase inhibitor of cAMP-dependent protein kinase in mouse.

  1993cited by this paper
• Isolation and characterization of cDNA clones for an inhibitor protein of cAMP-dependent protein kinase.

  1991cited by this paper
• A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

  1990cited by this paper
• The classification of prostaglandin DP‐receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist

  1989cited by this paper
• AH6809, a prostaglandin DP‐receptor blocking drug on human platelets

  1988cited by this paper
• Evidence for homogeneity of thromboxane A2 receptor using structurally different antagonists.

  1988cited by this paper
• New evidence with selective agonists and antagonists for the subclassification of PGE2-sensitive (EP) receptors.

  1987cited by this paper
• Differential and common recognition of the catalytic sites of the cGMP-dependent and cAMP-dependent protein kinases by inhibitory peptides derived from the heat-stable inhibitor protein.

  1986cited by this paper
• Granulocyte-macrophage colony-stimulating factors

  1985cited by this paper
• Guanosine cyclic 3',5'-phosphate dependent protein kinase, a chimeric protein homologous with two separate protein families.

  1984cited by this paper
• pAx and competitive drug antagonism.

  1949cited by this paper

• The role of PGE2 and EP receptors on lung's immune and structural cells; possibilities for future asthma therapy.

  2022cites this paper
• Selectively targeting prostanoid E (EP) receptor-mediated cell signalling pathways: Implications for lung health and disease.

  2018cites this paper
• Role of Oxidized Lipids in Pulmonary Arterial Hypertension

  2016cites this paper
• The isoprostanes--25 years later.

  2015cites this paper
• Lipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipids.

  2014cites this paper
• Distinct PKA and Epac compartmentalization in airway function and plasticity.

  2013cites this paper
• Characterising the Mechanism of Airway Smooth Muscle β2 Adrenoceptor Desensitization by Rhinovirus Infected Bronchial Epithelial Cells

  2013cites this paper
• Isoprostanes as physiological mediators of transition to newborn life: novel mechanisms regulating patency of the term and preterm ductus arteriosus

  2012cites this paper
• β2-Adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids

  2011cites this paper
• Transcriptional regulation of inflammatory genes associated with severe asthma.

  2011cites this paper
• Isoprostanes and asthma.

  2011cites this paper
• Harnessing the clinical efficacy of phosphodiesterase 4 inhibitors in inflammatory lung diseases: dual-selective phosphodiesterase inhibitors and novel combination therapies.

  2011cites this paper
• Isoprostanes in fetal and neonatal health and disease.

  2010cites this paper
• Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages

  2009cites this paper
• Lipid metabolites as regulators of airway smooth muscle function.

  2009cites this paper
• Role of Prostanoid Production and Receptors in the Regulation of Retinal Endogenous Amino Acid Neurotransmitters by 8-Isoprostaglandin E2, Ex Vivo

  2009cites this paper
• Effect of beta2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A.

  2008cites this paper
• Effect of (cid:1) 2 -adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A

  2008cites this paper
• Isoprostanes and lung vascular pathology.

  2008cites this paper
• E-ring isoprostane augments cholinergic neurotransmission in bovine trachealis via FP prostanoid receptors.

  2007cites this paper
• Identification of prostaglandin E2 receptor subtype 2 as a receptor activated by OxPAPC

  2006cites this paper
• Vascular Endothelial Growth Factor Induction by Prostaglandin E2 in Human Airway Smooth Muscle Cells Is Mediated by E Prostanoid EP2/EP4 Receptors and SP-1 Transcription Factor Binding Sites*

  2005cites this paper